Annual accounts receivable:
$165.00M+$155.00M(+1550.00%)Summary
- As of today (September 16, 2025), PTGX annual accounts receivable is $165.00 million, with the most recent change of +$155.00 million (+1550.00%) on December 31, 2024.
- During the last 3 years, PTGX annual accounts receivable has risen by +$163.43 million (+10436.40%).
- PTGX annual accounts receivable is now at all-time high.
Performance
PTGX Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$23.36M+$538.00K(+2.36%)Summary
- As of today (September 16, 2025), PTGX quarterly accounts receivable is $23.36 million, with the most recent change of +$538.00 thousand (+2.36%) on June 30, 2025.
- Over the past year, PTGX quarterly accounts receivable has increased by +$23.32 million (+54232.56%).
- PTGX quarterly accounts receivable is now -92.21% below its all-time high of $300.04 million, reached on March 31, 2024.
Performance
PTGX Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
PTGX Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1550.0% | +10000.0% |
| 3 y3 years | +10000.0% | +10000.0% |
| 5 y5 years | +2342.6% | +679.5% |
PTGX Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -92.2% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -92.2% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -92.2% | >+9999.0% |
PTGX Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $23.36M(+2.4%) |
| Mar 2025 | - | $22.82M(-86.2%) |
| Dec 2024 | $165.00M(+1550.0%) | $165.00M(>+9900.0%) |
| Sep 2024 | - | $0.00(-100.0%) |
| Jun 2024 | - | $43.00K(-100.0%) |
| Mar 2024 | - | $300.04M(+2900.4%) |
| Dec 2023 | $10.00M(>+9900.0%) | $10.00M(>+9900.0%) |
| Sep 2023 | - | $0.00(-100.0%) |
| Jun 2023 | - | $39.00K(-23.5%) |
| Mar 2023 | - | $51.00K(+410.0%) |
| Dec 2022 | $10.00K | $10.00K(-92.0%) |
| Sep 2022 | - | $125.00K(+190.7%) |
| Jun 2022 | - | $43.00K(-99.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $25.15M(+1506.0%) |
| Dec 2021 | $1.57M(-35.4%) | $1.57M(-40.6%) |
| Sep 2021 | - | $2.64M(-62.7%) |
| Jun 2021 | - | $7.08M(+77.1%) |
| Mar 2021 | - | $4.00M(+64.7%) |
| Dec 2020 | $2.43M(-64.1%) | $2.43M(-13.0%) |
| Sep 2020 | - | $2.79M(-6.9%) |
| Jun 2020 | - | $3.00M(-16.6%) |
| Mar 2020 | - | $3.59M(-46.8%) |
| Dec 2019 | $6.75M | $6.75M(+247.3%) |
| Sep 2019 | - | $1.95M(-60.2%) |
| Jun 2019 | - | $4.89M(-3.4%) |
| Mar 2019 | - | $5.06M |
FAQ
- What is Protagonist Therapeutics, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual accounts receivable year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly accounts receivable year-on-year change?
What is Protagonist Therapeutics, Inc. annual accounts receivable?
The current annual accounts receivable of PTGX is $165.00M
What is the all time high annual accounts receivable for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual accounts receivable is $165.00M
What is Protagonist Therapeutics, Inc. annual accounts receivable year-on-year change?
Over the past year, PTGX annual accounts receivable has changed by +$155.00M (+1550.00%)
What is Protagonist Therapeutics, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of PTGX is $23.36M
What is the all time high quarterly accounts receivable for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly accounts receivable is $300.04M
What is Protagonist Therapeutics, Inc. quarterly accounts receivable year-on-year change?
Over the past year, PTGX quarterly accounts receivable has changed by +$23.32M (+54232.56%)